Selected article for: "histamine release and mast cell"

Author: Kakavas, Sotirios; Karayiannis, Dimitrios; Mastora, Zafeiria
Title: The Complex Interplay between Immunonutrition, Mast Cells, and Histamine Signaling in COVID-19
  • Cord-id: 00mrei4v
  • Document date: 2021_9_29
  • ID: 00mrei4v
    Snippet: There is an ongoing need for new therapeutic modalities against SARS-CoV-2 infection. Mast cell histamine has been implicated in the pathophysiology of COVID-19 as a regulator of proinflammatory, fibrotic, and thrombogenic processes. Consequently, mast cell histamine and its receptors represent promising pharmacological targets. At the same time, nutritional modulation of immune system function has been proposed and is being investigated for the prevention of COVID-19 or as an adjunctive strateg
    Document: There is an ongoing need for new therapeutic modalities against SARS-CoV-2 infection. Mast cell histamine has been implicated in the pathophysiology of COVID-19 as a regulator of proinflammatory, fibrotic, and thrombogenic processes. Consequently, mast cell histamine and its receptors represent promising pharmacological targets. At the same time, nutritional modulation of immune system function has been proposed and is being investigated for the prevention of COVID-19 or as an adjunctive strategy combined with conventional therapy. Several studies indicate that several immunonutrients can regulate mast cell activity to reduce the de novo synthesis and/or release of histamine and other mediators that are considered to mediate, at least in part, the complex pathophysiology present in COVID-19. This review summarizes the effects on mast cell histamine of common immunonutrients that have been investigated for use in COVID-19.

    Search related documents:
    Co phrase search for related documents
    • acute lung injury and adaptive immune response innate: 1, 2, 3, 4, 5
    • acute lung injury and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute lung injury and adaptive innate immunity: 1, 2, 3, 4
    • acute lung injury and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury and lung injury progress: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute lung injury and lung macrophage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • acute lung injury participate and lung injury: 1
    • adaptive immune response and adjuvant agent: 1
    • adaptive immune response and lung function: 1, 2, 3, 4
    • adaptive immune response and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • adaptive immune response and lung macrophage: 1
    • adaptive immune response innate and lung function: 1, 2, 3
    • adaptive immune response innate and lung injury: 1, 2, 3, 4, 5, 6, 7
    • adaptive innate and adjuvant agent: 1
    • adaptive innate and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • adaptive innate and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • adaptive innate and lung macrophage: 1, 2, 3
    • adaptive innate immunity and adjuvant agent: 1